EFFECT OF ALIROCUMAB ON FIRST AND TOTAL REVASCULARIZATIONS IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN THE ODYSSEY OUTCOMES TRIAL
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)30784-1
Abstract: Background On urban roads, road users interact in a highly complex environment. Few previous multivariable studies investigated the association between the built urban environment (including the road, roadside and human activity) and crashes. Roadside design… read more here.
Keywords: alirocumab first; road segments; road; effect alirocumab ... See more keywords
Effect of alirocumab on postprandial hyperlipidaemia in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, cross‐over trial
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.1111/dom.16305
Abstract: Postprandial hyperlipidaemia (PPL), characterized by elevated triglyceride (TG) concentrations after a meal, is common in type 2 diabetes (T2D) and is often recognized as an independent cardiovascular risk factor. Here, we aimed to assess the… read more here.
Keywords: alirocumab postprandial; postprandial hyperlipidaemia; type diabetes; effect alirocumab ... See more keywords
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Sign Up to like & getrecommendations! Published in 2019 at "Circulation"
DOI: 10.1161/circulationaha.118.038840
Abstract: Supplemental Digital Content is available in the text. read more here.
Keywords: acute coronary; alirocumab mortality; effect alirocumab; coronary syndromes ... See more keywords